Beijing Chieftain Control Technology Group Co., Ltd. Class A

Beijing Chieftain Control Technology Group Co., Ltd. Class A

SSZSE:300430
3.30
CNY
-0.21
(-5.98%)
-3.68EPS
1.13BMarket Cap
Apr 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.65
1.81
1.58
1.62
2.17
2.56
2.54
2.78
3.38
3.59
4.35
3.58
1.72
1.51
Basic EPS, GAAP
0.28
0.3
0.25
0.23
0.35
0.38
0.3
0.22
0.38
0.46
0.63
0.36
-3.22
-3.58
Free Cash Flow per Basic Share
-0.02
0.05
-0.54
-0.18
-0.18
-0.28
-0.2
-0.01
-0.4
-0.41
-0.39
0.17
-0.38
- -
Dividend per Share
0.01
0.02
0.01
0.05
0.04
0.04
0.02
0.03
0.06
0.08
0.11
0.16
0.14
0.09
Book Value per Share
1.48
1.78
2.62
2.8
5.63
5.97
6.27
6.49
6.75
7.22
7.86
8.17
4.91
4.8
Tangible Book Value per Share
1.31
1.6
2.49
2.67
3.64
3.9
4.1
4.33
4.62
5.1
5.75
6.07
3.62
3.52
Basic Weighted Avg Shares
175
176
218
230
256
269
271
274
271
271
270
268
273
273
Sales/Revenue/Turnover
288
319
344
373
555
689
689
764
915
974
1,176
958
470
412
Operating Margin (%)
19.19
19.66
17.47
17.27
18.14
18.61
15.4
13.87
18.04
18.03
21.92
15.2
-28.34
-54.13
Depreciation Expense
5
5
5
9
12
15
16
17
22
25
35
44
48
- -
Net Income, GAAP
49
52
54
54
90
102
81
60
103
125
170
97
-879
-977
Effective Tax Rate (%)
14.82
14.67
13.99
13.15
13.66
12.67
9.4
4.35
7.64
9.82
9.11
4.65
- -
- -
Profit Margin (%)
16.93
16.3
15.56
14.4
16.14
14.85
11.81
7.9
11.23
12.81
14.47
10.08
-186.95
-237.35
Working Capital
129
183
408
444
767
795
657
659
633
605
785
665
-213
-209
LT Debt
27
31
- -
- -
- -
- -
- -
56
124
136
202
152
113
111
Total Equity
260
312
612
655
1,534
1,639
1,726
1,786
1,864
1,994
2,165
2,234
1,306
1,271
Return on Invested Capital (%)
17.92
15.6
10.08
8.2
8.09
6.42
4.71
3.25
5.12
5.61
6.69
3.28
- -
- -
Return on Capital (%)
18.87
16.48
11.14
8.49
8.23
6.32
4.74
3.45
5.27
5.89
7.42
4.46
- -
- -
Return on Common Equity (%)
20.71
18.24
11.61
8.49
8.19
6.48
4.89
3.48
5.7
6.54
8.25
4.41
-49.23
-54.54

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
555
592
708
LT Borrowings
118
103
110
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
273
273
273
Market Capitalization
4,762
1,193
1,133

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,430
1,506
1,505
Cash, Cash Equivalents & STI
139
91
80
Accounts Receivable, Net
512
536
546
Inventories
528
661
665
Total Current Liabilities
1,673
1,735
1,714
Payables & Accruals
- -
- -
- -
ST Debt
555
592
708
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.86%
-3.68%
-41.53%
Free Cash Flow
331.47%
685.53%
-331.71%
Net Income, GAAP
-89.12%
-185.22%
-1,010.81%
Sales/Revenue/Turnover
6.96%
-4.51%
-50.91%
Total Cash Common Dividend
76.65%
38.21%
-14.54%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
268
376
151
163
958
2025
189
219
- -
-163
470
2026
221
127
227
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.19
0.05
-0.01
0.36
2025
0.05
0.14
- -
-3.47
-3.22
2026
-0.22
0.11
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.02
0.08
0.04
0.16
2025
0.03
0.02
- -
0.03
0.14
2026
0.02
0.02
0.03
- -
- -

Company Description

CEO
Yi Liang
Full Time Employees
1,702
Sector
Producer manufacturing
Industry
Industrial machinery
Address
No. 27 Qingfeng West Road Beijing BE China 102600
IPO Date
Mar 19, 2015
Business
Beijing Chieftain Control Technology Group Co., Ltd., which began operations in 2003, is a prominent Chinese enterprise delivering sophisticated automation solutions and medical equipment. The company operates across two distinct segments, primarily serving the biological and pharmaceutical intelligent manufacturing sector, alongside the rapidly expanding rehabilitation medical equipment domain. In its intelligent manufacturing division, the company develops and supplies comprehensive systems for biological and pharmaceutical production processes. This includes advanced powder handling apparatus like dust-free crushing and pulse air mixing systems, automated lifting hopper mixers, sterile feeding stations, and vacuum conveyance units, among other metering and packaging solutions. It also offers specialized aseptic isolation equipment for packaging, batching, and reactor feeding, alongside gas chlorine dioxide sterilization technologies and intelligent packaging machinery. Furthermore, the company provides essential pharmaceutical and chemical equipment, encompassing extraction, evaporation, concentration, purification, separation, fermentation, distillation, and drying units. Complementing these offerings are precision valve products, such as diaphragm and globe valves, and professional medical pumps. These offerings are applied across diverse industries including pharmaceutical, chemical, food, additive, and power generation. The rehabilitation medical segment offers holistic solutions to various healthcare providers, including medical and rehabilitation institutions, elderly care facilities, and sports organizations. The company’s Longest brand products span rehabilitation assessment, training, physical therapy, and complete rehabilitation specialty programs. Notably, this sector has recently expanded its product lines to cater to the pet market, demonstrating a broader application of its medical instrument and rehabilitation expertise. Headquartered in Beijing, China, the company was publicly listed on the Shenzhen Stock Exchange GEM in 2015 and adopted its current name, Beijing Chieftain Control Technology Group Co., Ltd., in September 2024.